Our findings shed some light on the complexity of IR signaling, demonstrate an important role of SMPDL3b in the modulation of insulin signaling, and provide the first evidence that biologically active lipids, such as C1P may represent treatment options for complications of diabetes associated with high cardiovascular morbidity and mortality such as DKD. This evidence concerns the gene INS and diabetes mellitus.